Zio AT ECG Monitoring System vs Reveal LINQ Insertable Cardiac Monitor

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 70/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
Zio AT ECG Monitoring System
by iRhythm Technologies, Inc.
VS
Reveal LINQ Insertable Cardiac Monitor
by Medtronic

AI Verdict

Tool A, the Zio AT ECG Monitoring System, is a wearable, non-invasive solution for continuous cardiac monitoring up to 14 days, focusing on comprehensive arrhythmia detection and reporting. In contrast, Tool B, the Reveal LINQ Insertable Cardiac Monitor, is an implantable device offering significantly longer-term (up to 4.5 years) subcutaneous ECG monitoring, with its AI specifically designed to reduce false alerts. The primary distinction lies in their deployment method (wearable vs. implantable) and monitoring duration, catering to different diagnostic and long-term management needs.

Choose Zio AT ECG Monitoring System if…

Choose Zio AT if you require continuous, real-time ECG monitoring for up to 14 days to quickly detect and diagnose symptomatic or asymptomatic cardiac arrhythmias. This system is ideal for patients needing immediate, actionable insights over a defined short-to-medium term period, leveraging a wearable patch for ease of use and comprehensive reporting.

View Zio AT ECG Monitoring System →

Choose Reveal LINQ Insertable Cardiac Monitor if…

Choose Reveal LINQ if you need extremely long-term, continuous cardiac monitoring for up to 4.5 years, particularly for infrequent or cryptogenic events where a wearable device might not capture the arrhythmia. This implantable monitor is well-suited for patients requiring extended monitoring without the need for patient compliance with a patch, and benefits from AI algorithms to reduce false alerts.

View Reveal LINQ Insertable Cardiac Monitor →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Zio AT ECG Monitoring System Reveal LINQ Insertable Cardiac Monitor
Pricing Contact for pricing Contact vendor
Deployment Cloud-based (data analytics and clinician portal) Implantable device with data transmitted to a cloud-based platform (CareLink™ network) via patient smartphone app or home communicator.
BAA Available Yes AI-estimated Yes AI-estimated
FDA Status Cleared AI-estimated Yes AI-estimated
HIPAA Yes AI-estimated Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Zio AT ECG Monitoring System

The Zio AT system is a non-invasive, patient-applied patch, making its initial setup and daily use significantly simpler for the patient. In contrast, the Reveal LINQ requires a surgical implantation procedure, presenting a higher initial barrier to patient usability.

Clinical Value

Reveal LINQ Insertable Cardiac Monitor

The Reveal LINQ offers significantly longer monitoring duration (4.5 years vs. 14 days), which is crucial for detecting infrequent or elusive arrhythmias over an extended period. Furthermore, its AccuRhythm AI specifically targets reducing false alerts, enhancing diagnostic accuracy and reducing clinician burden, providing a clear clinical advantage.

Pricing & Value

Tie

Both tools have undisclosed pricing, making a direct comparison of their cost-effectiveness impossible. Without transparent pricing details for either the service fees of Zio AT or the device cost of Reveal LINQ, it is not feasible to determine which offers better value.

Enterprise Readiness

Tie

Both systems demonstrate strong enterprise readiness, offering cloud-based data management, HIPAA compliance, and Business Associate Agreements (BAAs). Both are backed by established companies with robust infrastructure suitable for healthcare integration.

Innovation

Reveal LINQ Insertable Cardiac Monitor

While both utilize AI, the Reveal LINQ's AccuRhythm AI specifically innovates by significantly reducing false alerts, a critical improvement for diagnostic accuracy and efficiency. Its implantable nature with a 4.5-year battery life and remote programming capabilities also represents a higher degree of device innovation for long-term, passive monitoring.

Support & Docs

Reveal LINQ Insertable Cardiac Monitor

Medtronic provides a highly structured and comprehensive support system for the Reveal LINQ, including a dedicated Manual Library for various guides and separate phone lines for technical and patient services. This robust framework, coupled with extensive patient education materials, suggests a slightly more thorough and accessible support infrastructure for a complex implantable device compared to Zio AT's offerings.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Zio AT ECG Monitoring System Reveal LINQ Insertable Cardiac Monitor
Device Type Wearable mobile cardiac telemetry (MCT) service (Zio AT patch) Insertable Cardiac Monitor (ICM)
Company iRhythm Technologies, Inc. Medtronic
AI Algorithm FDA-cleared deep-learned AI algorithm (ZEUS System) AccuRhythmu2122 AI algorithms
Monitoring Duration/Battery Life Continuous, uninterrupted ECG recording for up to 14 days 4.5-year battery longevity (nominal settings)
Patient Mobile App MyZiou00ae patient mobile app for symptom logging and education MyCareLink Heartu2122 mobile app for patient data transmission
Clinician Portal/Platform ZioSuiteu00ae clinician portal and mobile app CareLinku2122 network (cloud-based platform)

Videos

Demos, reviews, and walkthroughs featuring Zio AT ECG Monitoring System and Reveal LINQ Insertable Cardiac Monitor.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

The Zio AT is a wearable patch designed for continuous ECG recording for up to 14 days. In contrast, the Reveal LINQ is an insertable cardiac monitor that provides continuous subcutaneous ECG monitoring with a significantly longer battery longevity of 4.5 years.
The Zio AT utilizes an FDA-cleared deep-learned AI algorithm (ZEUS System) for general arrhythmia detection and comprehensive reporting. The Reveal LINQ features AccuRhythm AI algorithms specifically designed to reduce false alerts for conditions like atrial fibrillation and pause events, enhancing diagnostic yield.
Patients wear the Zio AT patch, which transmits data wirelessly via a gateway, and can use the MyZio app for symptom logging. The Reveal LINQ is an implanted device, with data transmitted to a cloud-based platform (CareLinku2122 network) via the MyCareLink Heartu2122 mobile app or MyCareLink Relayu2122 home communicator.
Clinicians access Zio AT data and comprehensive end-of-wear reports through the ZioSuiteu00ae clinician portal and mobile app. For the Reveal LINQ, data is transmitted to the cloud-based CareLinku2122 network, offering an enhanced ECG experience for clinical adjudication.
The Reveal LINQ Insertable Cardiac Monitor is MRI compatible at u2264 3T with no post-insertion waiting required. The Zio AT ECG Monitoring System is considered MR Unsafe and should not be exposed to an MRI environment due to potential risks like projectile injury, thermal injury, and device malfunction.
The Zio AT patch is a single-use device worn for up to 14 days for continuous recording. The Reveal LINQ Insertable Cardiac Monitor offers a long-term solution with a nominal battery longevity of 4.5 years.

More Comparisons

Assert-IQ vs Rapid Enterprise Platform
AISAP Cardio vs Rapid Enterprise Platform
AngioWaveNet vs Rapid Enterprise Platform
CorVista System with PH Add-On vs Rapid Enterprise Platform

More matchups featuring Zio AT ECG Monitoring System or Reveal LINQ Insertable Cardiac Monitor

Backers

Who funded each tool's parent company.

Zio AT ECG Monitoring System

AI Tool Finder
AI-powered search. Results may not be comprehensive.